text:
Samsung announces the 'versatile' Galaxy Tab A (8.0") tablet
Samsung has announced an upcoming tablet, the latest addition to the Galaxy range. The Samsung Galaxy Tab A (8.0") -- also known as the Galaxy Tab A (2017) -- has been "designed for the whole family" and is a budget tablet that you won't mind sharing it with, or giving to, the kids.
The specs are, generally speaking, nothing to get too excited about, but that's not the aim of this tablet. The metal body gives an air of quality to what Samsung describes as "an everyday, versatile tablet," and a 5,000mAh battery can power the device for up to 14 hours. Although this is pitched as a family device, there is a strong focus on children.
The tablet will ship with Android 7.1.1, and Samsung is not saying whether there is an Oreo upgrade in the pipeline. Multiple accounts can be set up so kids and parents can keep their apps and settings separate, and Parental Controls are available to place limits on what can be done. A free three-month subscription to YouTube Red is included for ad-free access to YouTube Red content.
Samsung says:
Kids Mode features exciting games, videos and content from partners including 5,000 videos and games from The LEGO Group as well as a social network themed LEGO Life app with exclusive sticker content. The Galaxy Tab A also comes with a new native block coding app called Crocro Adventure; with this app, kids will be able to learn about block coding and programming through fun games teaching valuable logical thinking skills. Kids Mode now also features Value Pack options so users can download highly popular apps like LEGO Batman: Beyond Gotham, LEGO Ninjago: Shadow of Ronin, Toca Hair Salon 3 and BRIO World -- Railway at no cost.
Here are the specs as shared by Samsung:
Dimensions: 212.1 x 124.1 x 8.9 mm
Weight: 360g (Wi-Fi), 364g (LTE)
Display: 8.0-inch WXGA (1280 x 800, 16:10) TFT, 480nits
Processor: Quad Core 1.4GHz, Qualcomm Snapdragon 425
OS: Android 7.1.1
Memory: 2GB (RAM) + 32GB, Micro SD up to 256GB
Camera: Front: 5MP FF, Rear: 8MP AF with Flash
Battery: 5,000mAh
Port: USB 2.0 (Type C)
Connectivity: Wi-Fi 802.11 a/b/g/n, Wi-Fi Direct, Bluetooth v4.2
The Samsung Galaxy Tab A (2017) goes on sale in the US on November 1. It will be available direct from Samsung for $229.99.


Alright guys, I have a confession… I have an obsession with bathing suits. It's to the point that I should probably never purchase another bikini again. The summer is almost over *tears* and I was holding out but I think I found a suit worth splurging for.
See my favs below and visit the sight for all the lines options.
Tags: aael, bikinis, Clothing, neoprene, shopping, Style, Summer Style, Swimsuits, swimwear, Triangl, Vacations. Bookmark the permalink.


To choose durable, comfortable diamond supply blue online, DHgate Australia site is a great destination. We offer varieties of cheap czech diamond & diamond cuban link in fashion which contain the one satisfying your taste. Best diamond head tiara come from comparsion and our platform provides you simple way to compare in several dimensions. Purchase stylish unfinished diamond painting at a cost-efficient price with free delivery to Australia from au.dhgate.com.


text:
Q: How can I deploy my database from SQL Server 2008 Express to Azure SQL Database I am using Visual Studio Community 2013, SQL Server 2008 R2 Express Edition for an MVC web application using entity framework code first migrations for my database.
I am trying to get my local application hosted on the Microsoft Azure platform.
I have registered for a trial account which expires in 30 days, and deployed my MVC5 app out which has been successful.
However, this app requires a database which I am struggling to deploy.
What is the easiest way to get my database deployed out to Azure as I do not seem to have the :
"Tasks" -> "Deploy Database to Microsoft Azure SQL Database" option available to me in SSMS.
I have extracted a Data-tier Application of my local database and have it stored on my C drive, however if I connect to my Azure Account in a second window, and right click the server then select Deploy Data-tier Application, it fails on "Creating schema object in database" with the following error:

TITLE: Microsoft SQL Server Management Studio
An exception occurred while executing a Transact-SQL statement or
  batch. (Microsoft.SqlServer.ConnectionInfo)
------------------------------ ADDITIONAL INFORMATION:
Users cannot be mapped to certificates, asymmetric keys, or Windows
  logins in this version of SQL Server. (Microsoft SQL Server, Error:
  40528)

I'm assuming its tried to create my local account plus the IIS APPPOOL account I had to set up to host the website on my local network, however I do not see a way of removing them from the .dacpac export.
When I refresh the Databases node, there is still no database, I'm fairly lost now as to how I might get my db deployed to this server?

A: If you can extract a compatible Data-tier application and then Deploy it to your target server using your current version of Management studio, then this approach should work, see this link for more reading on ensuring your database is compatible.
Failing this, as was in my case. I downloaded Management Studio 2015, which gave me the option to deploy database to Azure by simply right clicking the required database.
Again, this threw up the error regarding my database level IISAPPOOL user, but not my server account user. As a way around this, I took a backup/restore of the database and removed this user then deployed the copy database obviously minus the problem account.
Now all that was left to do was add a transform to my Release web.config with the Azure connection string as provided on the Azure dashboard, and re-deploy the website.
Problem solved.

redpajama_set_name: RedPajamaStackExchange


text:
NIDA 5 Test Kits Drugs Combination
NIDA the National Institute on Drug Abuse was founded in 1974 as part of the United States Institute of Human Health. Both are under the US Department of Health and Human Services. Its primary function is to be the premier agency that would deal with the research, treatment, prevention and training services and data collection on the extent of drug abuse in the United States. They were later given more power in 1981 by a mandate from Congress through the Block Grant Program that gave it more control over the treatment and prevention of drug abuse. NIDA established the Center on AIDS and Other medical Consequences of Drug Abuse in 1998 to coordinate a multi-disciplinary research program on drugs abuse and HIV/AIDS. They launched the National Drug Abuse Treatment Clinical Trials Network to test and rapidly determine the effectiveness of both pharmacological and behavioral treatments that have been developed. In the year 2000, NIDA distributes its CLINICAL TOOLBOX, a collection of the latest scientific publication and other materials on drug addiction treatment. In 2002 a NIDA funded research developed Buprenorphine as treatment for opiate addiction. Also in the same year they teamed up with Scholastic and increased drug addiction education in schools in providing science-based information to school children in the US.
The first mandatory drug testing guidelines for the Federal Government were published and made into law on April 11, 1988. It was revised three times with the last one on 2004 which further expanded the law and defined further the results verification and determination of urine drug testing in the federal workplace. The private sector soon followed suit as mandated by the federal government to endow the benefits of a Drug-Free workplace.
NIDA-5 is a set of Federal Government guidelines that was composed by both the US-NIDA and SAMHSA (Substance Abuse and Mental Health Services Administration) that directed companies and federal agencies to screen employees for substance abuse. This was aimed at those individuals who do safety sensitive jobs such as those involved in transportation and/or oil and gas related occupations. The screening process must cover five drug categories namely; THC (marijuana, Cannabinoids), Cocaine (crack, cocaethelyne, benzoylecognine), Amphetamines (speed, methamphetamine), Opiates (Heroin, codeine, morphine, opium) and Phencyclidine (PCP). Although the testing procedures for these individual drug categories were established decades ago by the US Food and Drugs Administration and NIDA the guidelines issued by the Federal Government now required all 5 of these substances to be tested and the results quantified as a whole rather than individual screening results.
This was brought up by the increasing rates of accidents on all forms of transportation that were caused by substance abuse from the above mentioned most common types. NIDA has been at the forefront of funding and research on the effects of drugs and addiction. They provide the public with support by publishing materials or documents that serve as guides and basis for drug addiction and treatment throughout the world in conjunction with the other branches of the Department of health.
The testing of these 5 substances can be carried out on several biological samples such as saliva, hair, urine, blood and sweat. All these biological specimens have the ability to indicate the presence and abuse of one or several drugs listed as addictive. There are two stages for drug use detection, the first being the most common screening is usually done to detect generally the presence of any banned substances. If there is a positive result upon screening, a more detailed laboratory examination is conducted through accredited laboratories who can process and come up with very accurate results through either mass spectrometry or gas chromatography.
Samples that are obtained for the testing of drugs can either be tested as is of further processed such as blood samples, hair and sweat. Blood samples have to be separated into the two components; plasma and the solid blood components of which plasma is the most likely subject for testing. Hair samples are first washed in a solution to eliminate any substance that may occur on the surface of the hairs which is then dissolved and analyzed through gas chromatography. Sweat is extracted from patches and then analyzed in the same manner as hair follicles.
Urine and saliva can be tested using kits that have media where it travels up through capillary action and activates chemicals placed on these strips showing up as different banded colors.
The NIDA has published a detection period table for each substance that may vary according to the frequency of use, age, body mass, health, tolerance and urine ph or acidity. For example, Amphetamines can be detected in saliva within 3 days, urine 1-4 days and in hair samples within 90 days. The specified table can be found on most drug testing facilities or government web sites of the Department of Human Health, NIDA and others.
The testing for these substances are usually performed during pre-employment health tests so as to screen possible problem employees who are drug users. They are quite cheap for only the basic requirements of NIDA-5 are tested making it cheaper to implement. This is done through in-house testing or through accredited laboratories who are paid by the company to conduct the collection and testing for them. Some laboratories will do tests on other newer substances classified as addicting which could cost more making them less attractive to employers. Random drug-testing is a controversial procedure where policing agencies conduct random testing of individuals who can either be a randomly selected individual or a known drug user. They are now conducted in corporations, drug rehab centers, prisons, military institutions, government agencies, schools, police and fire departments. They are done to discourage the use of prohibited substances through randomized testing.
Another avenue where these substances are tested for is during post-incident inquiry. This is not a preferred testing procedure due to the stress of being involved in any traumatic incident. It is done to protect firms from liability as a result of an employee that was involved in an accident while under the influence of prohibited substances.

redpajama_set_name: RedPajamaCommonCrawl


text:
Antonina Mikocka-Walus
Prof Antonina Mikocka-Walus
Melbourne Burwood Campus
Doctor of Philosophy, University of Adelaide, 2008
antonina.mikockawalus@deakin.edu.au
https://www.deakin.edu.au/mirth
Dr Antonina Mikocka-Walus is Professor of Health Psychology in the School of Psychology and the former Faculty of Health HDR Director. She is a psychologist with expertise in clinical health psychology, behavioural medicine and psychosomatic medicine. Her particular expertise is in psychogastroenterology. She graduated in psychology from the University of Warsaw, international political and economic relations from Warsaw School of Economics and Sciences Politiques de Paris, and medicine from the University of Adelaide. After completing her doctorate, she held a postdoctoral position in epidemiology and neuropsychology at Monash University. She later held senior roles at the University of South Australia and the University of York in the UK. She started her appointment at Deakin University in October 2016.
Read more on Antonina's profile
psychogastroenterology; psychotherapy; neuromodulators; telehealth; trials
Co-Creator and Champion, Deakin Early Careers Academic Futures (DECAF) Research Peer Mentoring Program, Deakin University
Chair, Program to Support Academic Careers Equitably (pACE), Faculty of Health, Deakin University
Leader, Loss, Recovery and Growth, Centre for Social & Early Emotional Development, Deakin University
Leader, Mind-Body Research in Health Laboratory (MiRth), School of Psychology, Deakin University
Adjunct Associate Professor in Psychology, University of Adelaide
Co-Chair, Research Mentorship Committee, The Rome Foundation's GastroPsychology Section
Teaching interests
Behavioural Medicine; Health Psychology; Chronic illness and Mental Health
Antonina has supervised 21 PhD, 12 Masters and 40 Honours students.
Units taught
HPS226 Health Psychology - Unit Chair
Antonina specialises in trials of psychological and psychiatric interventions to modify disease activity in chronic gastrointestinal conditions, women's health and cancer. She also conducts observational studies and systematic reviews on the relationship between anxiety, depression and disease activity in a variety of chronic diseases.
Antonina's field-weighted citation index (FWCI) in psychogastroenterology is 2.24, placing her in the 98th percentile worldwide. Her FWCIs in women's health and cancer are 2.2.
Antonina is among the top 2% most cited researchers worldwide.
Antonina is a grant panel member for: NHMRC and European Commission
Antonina is a grant assessor for: UK Medical Research Council, The Greek IBD research group, Physician Services Incorporated Foundation, Canada, Carnegie Trust for the Universities of Scotland, UK, La Caixa Foundation, Spain, The Luxembourg National Research Fund (FNR), CORE research program, Crohn's and Colitis UK, The Economic and Social Research Council, The National Institute for Health and Research, UK and The Swiss National Science Foundation
Antonina is Deputy Editor of Journal of Psychosomatic Research.
Centre for Social & Early Emotional Development (SEED)
Deakin University Staff Award 2018 for outstanding service in the role of the HDR Coordinator
Examples of Antonina's current projects include:
1. Acceptance Committment Therapy for Inflammatory Bowel Disease (with colleagues from Monash University, Swinburne University of Technology, University of Otago and Crohn's & Colitis Australia)
2. Cognitive-Behavioural Therapy and Yoga for Endometriosis (with colleagues from Barwon Health, Monash University and Jean Hailes For Women's Health)
3. Gut-directed Hypnotherapy for Inflammatory Bowel Disease (with colleagues from the University of Adelaide and Deakin)
4. COVID-19 and Mental Health in People with Gastrointestinal Disorders: An International Cohort (with colleagues from University of North Carolina, University of Manitoba, University of Leeds,University of Minnesota, Rush University, University of Nicosia, University of Coimbra, Medical University of Lodz, University Hospital Santiago de Compostela, Amsterdam University,University Hospital Tübingen, University Hospital Tübingen, Iuliu Hatieganu University of Medicine and Pharmacy and Hvidovre University Hospital)
5. Acceptance Committment Therapy for Stage 4 Cancer (with colleagues from Olivia Newton-John Cancer Wellness & Research Centre, Barwon Health, Monash Health, Prostate Cancer Foundation of Australia and Counterpart)
Online psychological interventions to reduce symptoms of depression, anxiety, and general distress in those with chronic health conditions: A systematic review and meta-analysis of randomized controlled trials
V White, J Linardon, J Stone, E Holmes-Truscott, L Olive, A Mikocka-Walus, C Hendrieckx, S Evans, J Speight
(2022), Vol. 52, pp. 548-573, Psychological Medicine, England, C1
Adapting 'Tame Your Gut' for patients with inflammatory bowel disease and co-morbid anxiety and/or depression
I Hanlon, C Hewitt, S Evans, J Taylor, C Selinger, A Mikocka-Walus
(2022), Vol. 27, pp. 58-68, Journal of Health Psychology, England, C1
Low Subjective Wellbeing Is Associated with Psychological Distress in People Living with Inflammatory Bowel Disease
C Emerson, M Fuller-Tyszkiewicz, R Orr, K Lyall, L Beswick, L Olive, D Skvarc, R Cummins, A Mikocka-Walus
(2022), Vol. 67, pp. 2059-2066, Digestive Diseases and Sciences, United States, C1
Pain catastrophizing, but not mental health or social support, is associated with menstrual pain severity in women with dysmenorrhea: A cross-sectional survey
S Evans, C Dowding, L Olive, L Payne, M Druitt, L Seidman, D Skvarc, A Mikocka-Walus
(2022), Vol. 27, pp. 1410-1420, Psychology, Health and Medicine, England, C1
COVID-19-related personal product shortages are associated with psychological distress in people living with gastrointestinal disorders: A cross-sectional survey
A Mikocka-Walus, D Skvarc, M van Tilburg, M Barreiro-de Acosta, F Bennebroek Evertsz, C Bernstein, J Burisch, N Ferreira, R Gearry, L Graff, S Jedel, A Mokrowiecka, A Stengel, S Knowles
(2022), Vol. 34, Neurogastroenterology and Motility, England, C1
People Living with Inflammatory Bowel Disease Want Multidisciplinary Healthcare: A Qualitative Content Analysis
M Feeney, A Chur-Hansen, A Mikocka-Walus
(2022), Vol. 29, pp. 570-577, Journal of Clinical Psychology in Medical Settings, Berlin, Germany, C1
Exploring the Relationship Between Self-Isolation and Distress Among People with Gastrointestinal Disorders During the COVID-19 Pandemic
A Mikocka-Walus, D Skvarc, M de Acosta, F Evertsz, C Bernstein, J Burisch, N Ferreira, R Gearry, L Graff, S Jedel, A Mokrowiecka, A Stengel, I Trindade, M van Tilburg, S Knowles
(2022), Vol. 29, pp. 654-665, Journal of Clinical Psychology in Medical Settings, United States, C1
Mental distress of parents with chronic diseases during the COVID-19 pandemic in Australia: A prospective cohort study
K Bik-Multanowska, A Mikocka-Walus, J Fernando, E Westrupp
(2022), Vol. 152, pp. 1-9, Journal of Psychosomatic Research, London, Eng., C1
Child and Parent Physical Activity, Sleep, and Screen Time During COVID-19 and Associations With Mental Health: Implications for Future Psycho-Cardiological Disease?
L Olive, E Sciberras, T Berkowitz, E Hoare, R Telford, A O'Neil, A Mikocka-Walus, S Evans, D Hutchinson, J McGillivray, M Berk, S Teague, A Wood, C Olsson, E Westrupp
(2022), Vol. 12, pp. 1-13, Frontiers in Psychiatry, Lausanne, Switzerland, C1
Mindfulness Practice Is Associated With Subjective Wellbeing Homeostasis Resilience in People With Crohn's Disease but Not Ulcerative Colitis
Kimina Lyall, Lauren Beswick, Subhadra Evans, Robert Cummins, Antonina Mikocka-Walus
Self-Worth Beliefs Predict Willingness to Engage in Psychotherapy for Fatigue in Inflammatory Bowel Disease
C Emerson, D Skvarc, M Fuller-Tyszkiewicz, L Olive, P Gibson, A Mikocka-Walus
(2022), pp. 1-11, Digestive Diseases and Sciences, Berlin, Germany, C1
Can an online expressive writing program support people with inflammatory bowel disease? A feasibility randomised controlled trial
D Skvarc, S Evans, S Cheah, M Cranney, B German, R Orr, C Emerson, L Olive, L Beswick, W Massuger, L Raven, A Mikocka-Walus
(2022), Vol. 48, Complementary Therapies in Clinical Practice, C1
Acceptance commitment therapy (ACT) for psychological distress associated with inflammatory bowel disease (IBD): protocol for a feasibility trial of the ACTforIBD programme
S Evans, L Olive, M Dober, S Knowles, M Fuller-Tyszkiewicz, O Eric, P Gibson, L Raven, R Gearry, A McCombie, L Van Niekerk, S Chesterman, D Romano, A Mikocka-Walus
(2022), Vol. 12, pp. 1-9, BMJ Open, London, Eng., C1
Lessons from implementing the Australian National Action Plan for Endometriosis
M Armour, J Avery, M Leonardi, L Van Niekerk, M Druitt, M Parker, J Girling, B McKinnon, A Mikocka-Walus, C Ng, R O'Hara, D Ciccia, K Stanley, S Evans
(2022), Vol. 3, pp. C29-C39, Reproduction and Fertility, C1
Peer review as a measurable responsibility of those who publish: The peer review debt index
J Fiedorowicz, M Kleinstäuber, C Lemogne, B Löwe, B Ola, A Sutin, S Wong, N Fabiano, M Tilburg, A Mikocka-Walus
(2022), Vol. 161, Journal of Psychosomatic Research, C1
Fear of COVID-19 Among Patients with Inflammatory Bowel Disease as Compared to Patients with Other Gastrointestinal Conditions
B Lo, M Barreiro-de Acosta, C Bernstein, J Burisch, N Ferreira, R Gearry, A Mikocka-Walus, A Mokrowiecka, I Trindade, S Knowles
(2022), Vol. 33, pp. 664-672, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, C1
Patients with inflammatory bowel disease at risk of sub-optimal outcomes report poorer biopsychosocial functioning than controls: data from two cross-sectional surveys
R Orr, D Skvarc, C Emerson, L Beswick, L Olive, A Mikocka-Walus
(2022), Psychology, Health and Medicine, C1
Psychotherapy appears to improve symptoms of functional dyspepsia and anxiety: systematic review with meta-analysis
A Mikocka-Walus, S Evans, J Linardon, H Wilding, S Knowles
The temporal effect of emotional distress on psychological and physical functioning in endometriosis: A 12-month prospective study
C Dowding, A Mikocka-Walus, D Skvarc, L Van Niekerk, M O'Shea, L Olive, M Druitt, S Evans
(2022), Applied Psychology: Health and Well-Being, C1
"It's Just Another Unfortunate Part of Being Female": A Qualitative Study on Dysmenorrhea Severity and Quality of Life
R Stokes, A Mikocka-Walus, C Dowding, M Druitt, S Evans
(2022), Journal of Clinical Psychology in Medical Settings, C1
Integrated Psychological Care Reduces Health Care Costs at a Hospital-Based Inflammatory Bowel Disease Service
T Lores, C Goess, A Mikocka-Walus, K Collins, A Burke, A Chur-Hansen, P Delfabbro, J Andrews
(2021), Vol. 19, pp. 96-103.e3, Clinical Gastroenterology and Hepatology, United States, C1
Lived experience in people with inflammatory bowel disease and comorbid anxiety and depression in the United Kingdom and Australia
A Mikocka-Walus, I Hanlon, M Dober, C Emerson, L Beswick, C Selinger, J Taylor, L Olive, S Evans, C Hewitt
(2021), Vol. 26, pp. 2290-2303, Journal of Health Psychology, England, C1
Clinical features, complications and treatment of rarer forms of maturity-onset diabetes of the young (MODY) - A review
R Aarthy, K Aston-Mourney, A Mikocka-Walus, V Radha, A Amutha, R Anjana, R Unnikrishnan, V Mohan
(2021), Vol. 35, Journal of Diabetes and its Complications, United States, C1
Perspectives on an Acceptance and Commitment Therapy (ACT) based program for patients with inflammatory bowel disease and comorbid anxiety and/or depressive symptoms
M Dober, A Mikocka-Walus, S Evans, L Beswick, C Emerson, L Olive
(2021), Vol. 31, pp. 668-681, Psychotherapy Research, England, C1
Perceptions of and opinions on a computerized behavioral activation program for the treatment of depression in young people: Thematic analysis
L Tindall, P Toner, A Mikocka-Walus, B Wright
(2021), Vol. 23, Journal of Medical Internet Research, Canada, C1
Phenotypes of Women with and Without Endometriosis and Relationship with Functional Pain Disability
S Evans, A Mikocka-Walus, L Olive, L Seidman, M Druitt, L Payne
(2021), Vol. 22, pp. 1511-1521, Pain medicine (Malden, Mass.), England, C1
Common mental disorders in irritable bowel syndrome: pathophysiology, management, and considerations for future randomised controlled trials
H Staudacher, A Mikocka-Walus, A Ford
(2021), Vol. 6, pp. 401-410, The Lancet Gastroenterology and Hepatology, Netherlands, C1
Finding the power within and without: How can we strengthen resilience against symptoms of stress, anxiety, and depression in Australian parents during the COVID-19 pandemic?
A Mikocka-Walus, M Stokes, S Evans, L Olive, E Westrupp
(2021), Vol. 145, Journal of Psychosomatic Research, England, C1
Subjective wellbeing in parents during the COVID-19 pandemic in Australia
E Westrupp, M Stokes, M Fuller-Tyszkiewicz, T Berkowitz, T Capic, S Khor, C Greenwood, A Mikocka-Walus, E Sciberras, G Youssef, C Olsson, D Hutchinson
Impact of Psychological Comorbidity on the Prognosis of Irritable Bowel Syndrome
V Goodoory, A Mikocka-Walus, Y Yiannakou, L Houghton, C Black, A Ford
(2021), Vol. 116, pp. 1485-1494, The American journal of gastroenterology, United States, C1
"I'm in iso all the time anyway": A mixed methods study on the impact of COVID-19 on women with endometriosis
S Evans, C Dowding, M Druitt, A Mikocka-Walus
A systematic review of psychological treatments to manage fatigue in patients with inflammatory bowel disease
C Emerson, P Barhoun, L Olive, M Fuller-Tyszkiewicz, P Gibson, D Skvarc, A Mikocka-Walus
The impact of the coronavirus (COVID-19) pandemic on individuals with gastrointestinal disorders: A protocol of an international collaborative study
N Ferreira, A Mikocka-Walus, M van Tilburg, L Graff, P Apputhurai, M Acosta, F Evertsz, J Burisch, B Lo, M Petrik, I Trindade, S Jedel, G Moser, A Mokrowiecka, C Bernstein, D Dumitrascu, A Ford, A Stengel, R Gearry, S Knowles
Yoga, cognitive-behavioural therapy versus education to improve quality of life and reduce healthcare costs in people with endometriosis: A randomised controlled trial
A Mikocka-Walus, M Druitt, M O'Shea, D Skvarc, J Watts, A Esterman, J Tsaltas, S Knowles, J Harris, C Dowding, E Parigi, S Evans
(2021), Vol. 11, BMJ Open, England, C1
Are Brief Psychological Therapies Effective for Adults Experiencing Common Mental Health Difficulties in Primary Care?
P Toner, S Ali, A Mikocka-Walus
(2021), Vol. 28, pp. 377-379, Clinical Psychology: Science and Practice, C1
Linking Homeostatically Protected Mood, Mindfulness, and Depression: A Conceptual Synthesis and Model of Moodfulness
K Lyall, A Mikocka-Walus, S Evans, R Cummins
(2021), Vol. 25, pp. 304-320, Review of General Psychology, C1
Treatment use and satisfaction in Australian women with endometriosis: a mixed-methods study
S Evans, V Villegas, C Dowding, M Druitt, R O'Hara, A Mikocka-Walus
(2021), Internal Medicine Journal, Australia, C1
Child, parent, and family mental health and functioning in Australia during COVID-19: comparison to pre-pandemic data
E Westrupp, C Bennett, T Berkowitz, G Youssef, J Toumbourou, R Tucker, F Andrews, S Evans, S Teague, G Karantzas, G Melvin, C Olsson, J Macdonald, C Greenwood, A Mikocka-Walus, D Hutchinson, M Fuller-Tyszkiewicz, M Stokes, L Olive, A Wood, J McGillivray, E Sciberras
(2021), European Child and Adolescent Psychiatry, Germany, C1
Extending the Common Sense Model to Explore the Impact of the Fear of COVID-19 on Quality of Life in an International Inflammatory Bowel Disease Cohort
B Hayes, P Apputhurai, A Mikocka-Walus, M Barreiro-de Acosta, C Bernstein, R Burgell, J Burisch, F Bennebroek Evertsz, N Ferreira, L Graff, I Trindade, R Gearry, B Lo, A Mokrowiecka, G Moser, M Petrik, A Stengel, S Knowles
(2021), Journal of Clinical Psychology in Medical Settings, United States, C1
"Poison" or "protection"? A mixed methods exploration of Australian parents' COVID-19 vaccination intentions
S Evans, A Klas, A Mikocka-Walus, B German, G Rogers, M Ling, J Fernando, E Kothe, E Westrupp
The Relationship Between Psychological Stress and Anxiety with Gastrointestinal Symptoms Before and During a 56 km Ultramarathon Running Race
C Urwin, L Main, A Mikocka-Walus, D Skvarc, S Roberts, D Condo, A Carr, L Convit, W Jardine, S Rahman, R Snipe
(2021), Vol. 7, Sports Medicine - Open, Switzerland, C1
Parent and child mental health trajectories April 2020 to May 2021: Strict lockdown versus no lockdown in Australia
E Westrupp, C Greenwood, M Fuller-Tyszkiewicz, C Olsson, E Sciberras, A Mikocka-Walus, G Melvin, S Evans, M Stokes, A Wood, G Karantzas, J Macdonald, J Toumbourou, S Teague, J Fernando, T Berkowitz, M Ling, G Youssef
(2021), Australian and New Zealand Journal of Psychiatry, England, C1
Monitoring Australian parents' shifting receptiveness to digital mental health interventions during the COVID-19 pandemic
J Linardon, E Westrupp, J Macdonald, A Mikocka-Walus, M Stokes, C Greenwood, G Youssef, S Teague, D Hutchinson, E Sciberras, M Fuller-Tyszkiewicz
Quality of Life and Diabetes in India: A scoping review
R Aarthy, R Aarthy, A Mikocka-Walus, A Mikocka-Walus, R Pradeepa, R Pradeepa, R Anjana, R Anjana, V Mohan, V Mohan, K Aston-Mourney, K Aston-Mourney
(2021), Vol. 25, pp. 365-380, Indian Journal of Endocrinology and Metabolism, Mumbai, India, C1
Psychological distress is highly prevalent in inflammatory bowel disease: a survey of psychological needs and attitudes
Antonina Mikocka-Walus, Massuger Wayne, Knowles Simon, Moore Gregory, Buckton Stephanie, Connell William, Pavli Paul, Raven Leanne, Andrews Jane
(2020), Vol. 4, pp. 166-171, Journal of gastroenterology and hepatology, Chichester, Eng., C1
Antidepressants in inflammatory bowel disease
A Mikocka-Walus, A Ford, D Drossman
(2020), Vol. 17, pp. 184-192, Nature Reviews Gastroenterology and Hepatology, England, C1
Quality of care in inflammatory bowel disease: actual health service experiences fall short of the standards
A Mikocka-Walus, W Massuger, S Knowles, G Moore, S Buckton, W Connell, P Pavli, L Raven, J Andrews
(2020), Vol. 50, pp. 1216-1225, Internal Medicine Journal, Australia, C1
The potential of integrated nurse-led models to improve care for people with functional gastrointestinal disorders: a systematic review
E Linedale, A Mikocka-Walus, P Gibson, J Andrews
(2020), Vol. 43, pp. 53-64, Gastroenterology nursing, Baltimore, Md., C1
Fatigue, Physical Activity, and Mental Health in People Living with Inflammatory Bowel Disease, Fibromyalgia, and in Healthy Controls: A Comparative Cross-Sectional Survey
L Olive, C Emerson, E Cooper, E Rosenbrock, A Mikocka-Walus
(2020), Vol. 43, pp. 172-185, Gastroenterology Nursing, Philadelphia, Pa., C1
Study Protocol for the COVID-19 Pandemic Adjustment Survey (CPAS): A Longitudinal Study of Australian Parents of a Child 0-18 Years
E Westrupp, G Karantzas, J Macdonald, L Olive, G Youssef, C Greenwood, E Sciberras, M Fuller-Tyszkiewicz, S Evans, A Mikocka-Walus, M Ling, R Cummins, D Hutchinson, G Melvin, J Fernando, S Teague, A Wood, J Toumbourou, T Berkowitz, J Linardon, P Enticott, M Stokes, J McGillivray, C Olsson
(2020), Vol. 11, Frontiers in Psychiatry, Switzerland, C1
From "It Has Stopped Our Lives" to "Spending More Time Together Has Strengthened Bonds": The Varied Experiences of Australian Families During COVID-19
S Evans, A Mikocka-Walus, A Klas, L Olive, E Sciberras, G Karantzas, E Westrupp
(2020), Vol. 11, Frontiers in Psychology, Switzerland, C1
Expressive writing to combat distress associated with the COVID-19 pandemic in people with inflammatory bowel disease (WriteForIBD): A trial protocol
A Mikocka-Walus, L Olive, D Skvarc, L Beswick, W Massuger, L Raven, C Emerson, S Evans
Psychogastroenterology for adults : a handbook for mental health professionals
S Knowles, L Keefer, A Mikocka-Walus
(2020), Abingdon, Eng., A7
edited book
Integrated Psychological Care is Needed, Welcomed and Effective in Ambulatory Inflammatory Bowel Disease Management: Evaluation of a New Initiative
(2019), Vol. 13, pp. 819-827, Journal of Crohn's and Colitis, England, C1
European Crohn's and Colitis Organisation Topical Review on Complementary Medicine and Psychotherapy in Inflammatory Bowel Disease
J Torres, P Ellul, J Langhorst, A Mikocka-Walus, M Barreiro-De Acosta, C Basnayake, N Ding, D Gilardi, K Katsanos, G Moser, R Opheim, C Palmela, G Pellino, S Van Der Marel, S Vavricka
(2019), Vol. 13, pp. 673-685D, Journal of Crohn's and Colitis, England, C1
Adjuvant therapy with antidepressants for the management of inflammatory bowel disease
Antonina Mikocka-Walus, Stephanie Prady, Justyna Pollok, Adrian Esterman, Andrea Gordon, Simon Knowles, Jane Andrews
(2019), Vol. 4, COCHRANE DATABASE OF SYSTEMATIC REVIEWS, England, C1
Psychological and mind-body interventions for endometriosis: A systematic review
S Evans, S Fernandez, L Olive, L Payne, A Mikocka-Walus
A clinician's quick guide to evidence-based approaches: irritable bowel syndrome
J Kantidakis, S Knowles, A Mikocka-Walus, T Taft, L Keefer, O Palsson, D Drossman
(2019), Vol. 23, pp. 283-285, Clinical psychologist, Chichester, Eng., C1
What Do Participants of the Crohn's and Colitis UK (CCUK) Annual York Walk Think of Their Inflammatory Bowel Disease Care? A Short Report on a Survey
A Mikocka-Walus, M Power, L Rook, G Robins
(2018), Vol. 41, pp. 59-64, Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates, United States, C1
Performance of an algorithm-based approach to the diagnosis and management of functional gastrointestinal disorders: A pilot trial
E Linedale, A Mikocka-Walus, A Vincent, P Gibson, J Andrews
Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses - Part i
S Knowles, L Graff, H Wilding, C Hewitt, L Keefer, A Mikocka-Walus
(2018), Vol. 24, pp. 742-751, Inflammatory Bowel Diseases, England, C1
Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses - Part II
S Knowles, L Keefer, H Wilding, C Hewitt, L Graff, A Mikocka-Walus
Systematic review with meta-analysis: online psychological interventions for mental and physical health outcomes in gastrointestinal disorders including irritable bowel syndrome and inflammatory bowel disease
I Hanlon, C Hewitt, K Bell, A Phillips, A Mikocka-Walus
(2018), Vol. 48, pp. 244-259, Alimentary Pharmacology and Therapeutics, England, C1
Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: A pilot randomized placebo-controlled trial
A Mikocka-Walus, P Hughes, P Bampton, A Gordon, M Campaniello, C Mavrangelos, B Stewart, A Esterman, J Andrews
Cognitive-behavioural therapy for inflammatory bowel disease: 24-month data from a randomised controlled trial
A Mikocka-Walus, P Bampton, D Hetzel, P Hughes, A Esterman, J Andrews
(2017), Vol. 24, pp. 127-135, International journal of behavioral medicine, New York, N.Y., C1-1
Effect of psychological therapy on disease activity, psychological comorbidity, and quality of life in inflammatory bowel disease: a systematic review and meta-analysis
D Gracie, A Irvine, R Sood, A Mikocka-Walus, P Hamlin, A Ford
Antidepressants in Inflammatory Bowel Disease: A Systematic Review
B Macer, S Prady, A Mikocka-Walus
Is behavioural activation effective in the treatment of depression in young people? A systematic review and meta-analysis
L Tindall, A Mikocka-Walus, D McMillan, B Wright, C Hewitt, S Gascoyne
(2017), Vol. 90, pp. 770-796, Psychology and Psychotherapy: Theory, Research and Practice, England, C1
Referrals to a tertiary hospital: A window into clinical management issues in functional gastrointestinal disorders
E Linedale, M Shahzad, A Kellie, A Mikocka-Walus, P Gibson, J Andrews
(2017), Vol. 1, pp. 84-91, JGH Open, Australia, C1
Patient satisfaction with treatment for alcohol use disorders: Comparing patients with and without severe mental health symptoms
S McCallum, J Andrews, M Gaughwin, D Turnbull, A Mikocka-Walus
(2016), Vol. 10, pp. 1489-1500, Patient Preference and Adherence, New Zealand, C1-1
'I'm a sick person, not a bad person': patient experiences of treatments for alcohol use disorders
S McCallum, A Mikocka-Walus, M Gaughwin, J Andrews, D Turnbull
(2016), Vol. 19, pp. 828-841, Health expectations, Chichester, Eng., C1-1
A cognitive behavioural therapy booklet for anxiety in functional gastrointestinal disorders: patient and health practitioner perspectives
A Mikocka-Walus, A Ahl, A Gordon, J Andrews
(2016), Vol. 26, pp. 164-177, Psychotherapy research, Abingdon, Eng., C1-1
Uncertain Diagnostic Language Affects Further Studies, Endoscopies, and Repeat Consultations for Patients With Functional Gastrointestinal Disorders
E Linedale, A Chur-Hansen, A Mikocka-Walus, P Gibson, J Andrews
(2016), Vol. 14, pp. 1735-1741.e1, Clinical Gastroenterology and Hepatology, United States, C1-1
Experience with and attitudes toward psychotherapy and antidepressants among patients with inflammatory bowel disease and functional gastrointestinal disorders: an online patient survey to inform system design
A Mikocka-Walus, J Andrews
(2016), Vol. 39, pp. 278-286, Gastroenterology nursing, Philadelphia, Pa., C1-1
Symptoms of Depression and Anxiety Are Independently Associated With Clinical Recurrence of Inflammatory Bowel Disease
A Mikocka-Walus, V Pittet, J Rossel, R von Känel
(2016), Vol. 14, pp. 829-835.e1, Clinical Gastroenterology and Hepatology, United States, C1-1
Controversies revisited: a systematic review of the comorbidity of depression and anxiety with inflammatory bowel diseases
A Mikocka-Walus, S Knowles, L Keefer, L Graff
(2016), Vol. 22, pp. 752-762, Inflammatory bowel diseases, Philadelphia, Pa., C1-1
Does computerized cognitive behavioral therapy help people with inflammatory bowel disease? A randomized controlled trial
A McCombie, R Gearry, J Andrews, R Mulder, A Mikocka-Walus
Physical activity habits, limitations, and predictors in people with inflammatory bowel disease: A large cross-sectional online survey
G Tew, K Jones, A Mikocka-Walus
(2016), Vol. 22, pp. 2933-2942, Inflammatory Bowel Diseases, England, C1
Vein Diameter for Peripherally Inserted Catheter Insertion: A Scoping Review
R Sharp, C Grech, A Fielder, A Mikocka-Walus, A Esterman
(2016), Vol. 21, pp. 166-175, JAVA - Journal of the Association for Vascular Access, C1
A public health intervention to change knowledge, attitudes and behaviour regarding alcohol consumption in pregnancy
F Crawford-Williams, A Fielder, M Steen, A Mikocka-Walus, A Esterman
(2016), Vol. 14, pp. 4-10, Evidence based midwifery, London, Eng., C1-1
S Knowles, A Mikocka-Walus
(2015), pp. xviii-xxiv, Psychological aspects of inflammatory bowel disease: a biopsychosocial approach, Hove, Eng., B1-1
Future directions in IBD: the biopsychosocial care, the integrated care
A Mikocka-Walus
(2015), pp. 216-222, Psychological aspects of Inflammatory Bowel Disease: a biopsychosocial approach, East Sussex, Eng., B1-1
An aggravated trajectory of depression and anxiety co-morbid with Hepatitis C: a within-groups study of 61 Australian outpatients.
B Stewart, D Turnbull, A Mikocka-Walus, H Harley, J Andrews
(2015), Vol. 11, pp. 174-179, Clinical practice and epidemiology in mental health, Sharjah, United Arab Emirates, C1-1
Continuity of care in dual diagnosis treatment: definitions, applications, and implications.
S McCallum, A Mikocka-Walus, D Turnbull, J Andrews
(2015), Vol. 11, pp. 217-232, Journal of dual diagnosis, Abingdon, Eng., C1-1
Measurement of vein diameter for peripherally inserted central catheter (PICC) insertion: an observational study
R Sharp, M Cummings, J Childs, A Fielder, A Mikocka-Walus, C Grech, A Esterman
(2015), Vol. 38, pp. 351-357, Journal of infusion nursing, Philadelphia, Pa., C1-1
"If you can have one glass of wine now and then, why are you denying that to a woman with no evidence": Knowledge and practices of health professionals concerning alcohol consumption during pregnancy.
F Crawford-Williams, M Steen, A Esterman, A Fielder, A Mikocka-Walus
(2015), Vol. 28, pp. 329-335, Women birth, Amsterdam, The Netherlands, C1-1
Doctor communication quality and friends' attitudes influence complementary medicine use in inflammatory bowel disease
R Mountifield, J Andrews, A Mikocka-Walus, P Bampton
(2015), Vol. 21, pp. 3663-3670, World journal of gastroenterology, Beijing, China, C1-1
"My midwife said that having a glass of red wine was actually better for the baby": a focus group study of women and their partner's knowledge and experiences relating to alcohol consumption in pregnancy
(2015), Vol. 15, pp. 1-11, BMC pregnancy and childbirth, London, Eng,, C1-1
Cognitive-behavioural therapy has no effect on disease activity but improves quality of life in subgroups of patients with inflammatory bowel disease: a pilot randomised controlled trial.
(2015), Vol. 15, pp. 1-12, BMC Gastroenterology, London, Eng., C1-1
The catheter to vein ratio and rates of symptomatic venous thromboembolism in patients with a peripherally inserted central catheter (PICC): A prospective cohort study
R Sharp, M Cummings, A Fielder, A Mikocka-Walus, C Grech, A Esterman
(2015), Vol. 52, pp. 677-685, International Journal of Nursing Studies, England, C1-1
Computerised Cognitive Behavioural Therapy for Psychological Distress in Patients with Physical Illnesses: A Systematic Review
A McCombie, R Gearry, J Andrews, A Mikocka-Walus, R Mulder
(2015), Vol. 22, pp. 20-44, Journal of Clinical Psychology in Medical Settings, United States, C1-1
Concerns and worries in people living with inflammatory bowel disease (IBD): A mixed methods study.
R Keeton, A Mikocka-Walus, J Andrews
(2015), Vol. 78, pp. 573-578, Journal of Psychosomatic Research, London, Eng., C1-1
A critical review of public health interventions aimed at reducing alcohol consumption and/or increasing knowledge among pregnant women.
F Crawford-Williams, A Fielder, A Mikocka-Walus, A Esterman
(2015), Vol. 34, pp. 154-161, Drug and alcohol review, Chichester, Eng., C1-1
Pilot CBT trial for anxiety in alcohol use disorders treatment
A Fielder, A Mikocka-Walus, S McCallum, B Stewart, P Alvaro, A Esterman
(2015), Vol. 8, pp. 179-192, Advances in dual diagnosis, Bingley, Eng., C1-1
Does the poor quality of Australian health education documentation undermine the message? A review of documents informing pregnant women about alcohol
(2015), Vol. 13, pp. 40-46, Evidence based midwifery, London, Eng., C1-1
The effects of a designer music intervention on patients' anxiety, pain, and experience of colonoscopy: a short report on a pilot study.
F Martindale, A Mikocka-Walus, B Walus, H Keage, J Andrews
(2014), Vol. 37, pp. 338-342, Gastroenterology nursing, Baltimore, Md., C1-1
The experience of anxiety in colonoscopy outpatients: a mixed-method study
N Rollbusch, A Mikocka-Walus, J Andrews
Changes in Australian injecting drug users' mental health problems and service uptake from 2006-2012
B Stewart, N Sindicich, D Turnbull, J Andrews, A Mikocka-Walus
The patient experience of a peripherally inserted central catheter (PICC): A qualitative descriptive study.
R Sharp, C Grech, A Fielder, A Mikocka-Walus, M Cummings, A Esterman
(2014), Vol. 48, pp. 26-35, Contemporary nurse, Maleny, Qld., C1-1
Covert dose reduction is a distinct type of medication non-adherence observed across all care settings in inflammatory bowel disease.
(2014), Vol. 8, pp. 1723-1729, Journal of Crohn's and Colitis, Oxford, Eng., C1-1
The patient experience of a Peripherally Inserted Central Catheter (PICC): a qualitative descriptive study
Rebecca Sharp, Carol Grech, Andrea Fielder, Antonina Mikocka-Walus, Melita Cummings, Adrian Esterman
(2014), Vol. 48, pp. 5066-5091, Contemporary Nurse, C1-1
How can we improve models of care in inflammatory bowel disease? An international survey of IBD health professionals.
A Mikocka-Walus, J Andrews, D Rampton, J Goodhand, J van der Woude, C Bernstein
(2014), Vol. 8, pp. 1668-1674, Journal of Crohns and Colitis, Amsterdam, The Netherlands, C1-1
Psychosocial issues in evidence-based guidelines on inflammatory bowel diseases: a review.
W Häuser, G Moser, P Klose, A Mikocka-Walus
(2014), Vol. 20, pp. 3663-3671, World journal of gastroenterology, Hong Kong, China, C1-1
Utilization and efficacy of internet-based eHealth technology in gastroenterology: a systematic review.
(2014), Vol. 49, pp. 387-408, Scandinavian journal of gastroenterology, Abingdon, Eng., C1-1
Attitudes towards antidepressants among people living with inflammatory bowel disease: an online Australia-wide survey.
(2014), Vol. 8, pp. 296-303, Journal of Crohns and Colitis, Oxford, Eng., C1-1
Colon cancer surveillance in inflammatory bowel disease: unclear gain but no psychological pain?
R Mountifield, P Bampton, R Prosser, A Mikocka-Walus, J Andrews
(2014), Vol. 44, pp. 131-138, Internal medicine journal, Milton, Qld., C1-1
Acceptability of psychotherapy, pharmacotherapy, and self-directed therapies in Australians living with chronic hepatitis C.
(2013), Vol. 20, pp. 427-439, Journal of clinical psychology in medical settings, New York, N.Y., C1-1
What are the implications of changing treatment delivery models for patients with inflammatory bowel disease : a discussion paper
A Mikocka-Walus, J Andrews, R von Känel, G Moser
(2013), Vol. 25, pp. 393-398, European journal gastroenterology and hepatology, Philadelphia, Pa., C1-1
A novel treatment resource for co-occurring symptoms
S Mccallum, A Mikocka-Walus, H Keage, O Churches, J Andrews
'Just to get it off my chest': Patients' views on psychotherapy in inflammatory bowel disease
A Mikocka-Walus, A Gordon, B Stewart, J Andrews
(2013), Vol. 13, pp. 227-234, Counselling and psychotherapy research, Abingdon, Eng., C1-1
Are self-administered or minimal therapist contact psychotherapies an effective treatment for irritable bowel syndrome (IBS): a systematic review
A Ahl, A Mikocka-Walus, A Gordon, J Andrews
(2013), Vol. 75, pp. 113-120, Journal of psychosomatic research, Amsterdam ,The Netherlands, C1-1
Vein measurement by peripherally inserted central catheter nurses using ultrasound: A reliability study
R Sharp, A Gordon, A Mikocka-Walus, J Childs, C Grech, M Cummings, A Esterman
(2013), Vol. 18, pp. 234-238, JAVA - Journal of the association for vascular access, Amsterdam, The Netherlands, C1-1
Antidepressants for depression during pregnancy: A systematic review protocol
A Gordon, A Mikocka-Walus, L Grzeskowiak, R Jayasekara
(2013), pp. 1-17, Cochrane database of systematic reviews, London, Eng., C1-1
"It's a tube up your bottom; it makes people nervous": the experience of anxiety in initial colonoscopy patients
A Mikocka-Walus, L Moulds, N Rollbusch, J Andrews
A magic pill? A qualitative analysis of patients' views on the role of antidepressant therapy in inflammatory bowel disease (IBD).
(2012), Vol. 12, pp. 1-9, BMC gastroenterology, London, Eng., C1-1
The role of antidepressants in the management of inflammatory bowel disease (IBD): a short report on a clinical case-note audit
(2012), Vol. 72, pp. 165-167, Journal of psychosomatic research, Amsterdam, The Netherlands, C1-1
An integrated model of care for inflammatory bowel disease sufferers in Australia: development and the effects of its implementation.
A Mikocka-Walus, D Turnbull, G Holtmann, J Andrews
(2012), Vol. 18, pp. 1573-1581, Inflammatory bowel diseases, Hoboken, N. J., C1-1
Integrated models of care in managing inflammatory bowel disease: a discussion
A Mikocka-Walus, J Andrews, C Bernstein, L Graff, J Walker, A Spinelli, S Danese, C van der Woude, J Goodhand, D Rampton, G Moser
(2012), Vol. 18, pp. 1582-1587, Inflammatory bowel diseases, Philadelphia, Pa., C1-1
Help-seeking and coping with the psychosocial burden of chronic hepatitis C: a qualitative study of patient, hepatologist, and counsellor perspectives
B Stewart, A Mikocka-Walus, H Harley, J Andrews
(2012), Vol. 49, pp. 560-569, International journal of nursing studies, Amsterdam, The Netherlands, C1-1
Anxiety and depression in Australian chronic hepatitis C outpatients: prevalence and predictors
B Stewart, A Mikocka-Walus, J Morgan, A Colman, M Phelps, H Harley, J Andrews
(2012), Vol. 20, pp. 496-500, Australasian psychiatry, London, Eng., C1-1
Predictors of postconcussive symptoms 3 months after mild traumatic brain injury
J Ponsford, P Cameron, M Fitzgerald, M Grant, A Mikocka-Walus, M Schönberger
(2012), Vol. 26, pp. 304-313, Neuropsychology, Washington, D.C., C1-1
Protection from traumatic brain injury in hormonally active women vs men of a similar age: a retrospective international study
J Yeung, A Mikocka-Walus, P Cameron, W Poon, H Ho, A Chang, C Graham, T Rainer
(2011), Vol. 146, pp. 436-442, Archives of surgery, Chicago, Ill., C1-1
Long-term outcomes after uncomplicated mild traumatic brain injury: a comparison with trauma controls
J Ponsford, P Cameron, M Fitzgerald, M Grant, A Mikocka-Walus
(2011), Vol. 28, pp. 937-946, Journal of neurotrauma, New Rochelle, N.Y., C1-1
Treatment of psychological co-morbidities in common gastrointestinal and hepatologic disorders
(2010), Vol. 1, pp. 64-71, World journal of gastrointestinal pharmacology and therapeutics, Pleasanton, Calif., C1-1
Determinants of resilience to cigarette smoking among young Australians at risk: an exploratory study
Y Colgan, D Turnbull, A Mikocka-Walus, P Delfabbro
(2010), Vol. 8, pp. 1-8, Tobacco induced diseases, London, Eng., C1-1
Aortic transection: demographics, treatment and outcomes in Victoria, Australia
R Hiller, A Mikocka-Walus, P Cameron
(2010), Vol. 27, pp. 368-371, Emergency medicine journal, London, Eng., C1-1
Motorcycle-related major trauma: on-road versus off-road incidence and profile of cases
A Mikocka-Walus, B Gabbe, P Cameron
(2010), Vol. 22, pp. 470-476, Emergency medicine Australasia, Milton, Qld., C1-1
Management of spleen injuries: the current profile
A Mikocka-Walus, H Beevor, B Gabbe, R Gruen, J Winnett, P Cameron
(2010), Vol. 80, pp. 157-161, ANZ journal of surgery, Milton, Qld., C1-1
Pre-hospital and in-hospital parameters and outcomes in patients with traumatic brain injury: a comparison between German and Australian trauma registries
D Engel, A Mikocka-Walus, P Cameron, M Maegele
(2010), Vol. 41, pp. 901-906, Injury, Amsterdam, The Netherlands, C1-1
Incidence and outcomes of major trauma assaults: a population-based study in Victoria
P O'Mullane, A Mikocka-Walus, B Gabbe, P Cameron
(2009), Vol. 190, pp. 129-132, Medical journal of Australia, Sydney, N.S.W., C1-1
Bicycling injuries and mortality in Victoria, 2001-2006
M Sikic, A Mikocka-Walus, B Gabbe, F McDermott, P Cameron
Epidemiology of major paediatric chest trauma
S Samarasekera, A Mikocka-Walus, W Butt, P Cameron
(2009), Vol. 45, pp. 676-680, Journal of paediatrics and child health, London, Eng., C1-1
Demographic associations with stage of readiness to screen for colorectal cancer
A Duncan, C Wilson, S Cole, A Mikocka-Walus, D Turnbull, G Young
(2009), Vol. 20, pp. 7-12, Health promotion journal of Australia, Clayton, Vic., C1-1
Psychogastroenterology: a call for psychological input in Australian gastroenterology clinics
A Mikocka-Walus, D Turnbull, J Andrews, N Moulding, I Wilson, G Holtmann
Can antidepressants influence the course of inflammatory bowel disease? The current state of research
A Mikocka-Walus, D Clarke, P Gibson
(2009), Vol. 5, pp. 48-53, European gastroenterology & hepatology review, London, Eng., C1-1
Mirjana Sikic, Antonina Mikocka-Walus, Belinda Gabbe, Francis McDermott, Peter Cameron
(2009), Vol. 190, pp. 295-295, Medical Journal of Australia (MJA), Melbourne, Vic., C1-1
The effect of functional gastrointestinal disorders on psychological comorbidity and quality of life in patients with inflammatory bowel disease
A Mikocka-Walus, D Turnbull, J Andrews, N Moulding, G Holtmann
(2008), Vol. 28, pp. 475-483, Alimentary pharmacology and therapeutics, Chichester, Eng., C1-1
Does psychological status influence clinical outcomes in patients with inflammatory bowel disease (IBD) and other chronic gastroenterological diseases: an observational cohort prospective study
A Mikocka-Walus, D Turnbull, N Moulding, I Wilson, G Holtmann, J Andrews
(2008), Vol. 2, pp. 1-9, BioPsychoSocial medicine, London, Eng., C1-1
Psychological problems in gastroenterology outpatients: a South Australian experience. Psychological co-morbidity in IBD, IBS and hepatitis C
A Mikocka-Walus, D Turnbull, J Andrews, N Moulding, I Wilson, H Harley, D Hetzel, G Holtmann
(2008), Vol. 4, pp. 1-8, Clinical practice and epidemiology in mental health, London, Eng., C1-1
Psychological comorbidity and complexity of gastrointestinal symptoms in clinically diagnosed irritable bowel syndrome patients
A Mikocka-Walus, D Turnbull, N Moulding, I Wilson, J Andrews, G Holtmann
(2008), Vol. 23, pp. 1137-1143, Journal of gastroenterology and hepatology, Milton, Qld., C1-1
"It doesn't do any harm, but patients feel better": a qualitative exploratory study on gastroenterologists' perspectives on the role of antidepressants in inflammatory bowel disease
Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: a literature review
Antidepressants and inflammatory bowel disease: a systematic review
(2006), Vol. 2, pp. 1-9, Clinical practice and epidemiology in health, London, Eng., C1-1
Antonina Mikocka-Walus, Andrea Fielder, Stephanie Prady, Adrian Esterman, Simon Knowles, Jane Andrews
(), Cochrane Database of Systematic Reviews, C1
Australian Competitive Grants
A Randomized Controlled Trial Comparing Yoga, Cognitive Behaviour Therapy and Education to Improve Quality of Life and Reduce Healthcare Costs in Endometriosis
A/Prof Subhadra Evans, Prof Antonina Mikocka-Walus, Prof Jennifer Watts, Prof Adrian Esterman, Dr David Skvarc
MRFF EPCDRI Endometriosis Research Grant
EndoCannED - Medicinal Cannabis for the reduction in emergency department presentations in people with endometriosis: a randomised, controlled feasibility study
Prof Antonina Mikocka-Walus, Dr Mike Armour, A/Prof Subhadra Evans, Dr Marilla Druitt, Dr Jeremy Furyk, Prof Jason Abbott, Dr Cecilia Ng, Dr Allie Eathorne, Dr Karen Oldfield, Dr Karen Semprini, Ms Katherine Stanley
DJPR Victorian Medical Research Acceleration Fund
Combating Distress In People With Inflammatory Bowel Disease: A Feasibility Trial
Prof Antonina Mikocka-Walus, A/Prof Subhadra Evans, Dr Lisa Olive, Dr David Skvarc, A/Prof Lauren Beswick, Mr Wayne Massuger, A/Prof Leanne Raven
2021: $500
2020: $4,500
Acceptance Commitment Therapy (ACT) for distress associated with inflammatory bowel disease (IBD): A randomised controlled trial of the ACTforIBD program
Prof Antonina Mikocka-Walus, A/Prof Subhadra Evans, Dr Lisa Olive, Mr Eric O, Prof Matthew Fuller-Tyszkiewicz
Litwin IBD Pioneers
Nocebo response to fermentable carbohydrate dietary challenge: A randomized double-blind placebo-controlled crossover challenge trial
Dr Heidi Staudacher, Prof Felice Jacka, Prof Antonina Mikocka-Walus
Rome Foundation Disorders of Gut-Brain Interaction International Research Award
Exploring financial burden and language barriers for people with endometriosis: A mixed methods survey
A/Prof Subhadra Evans, Prof Antonina Mikocka-Walus
Endo Help Foundation
Supporting recovery from the mental health impacts of the COVID - 19 (rural communities and young women)
Prof John Toumbourou, Dr Camille Deane, Prof Gery Karantzas, Prof Antonina Mikocka-Walus, A/Prof Elizabeth Westrupp, A/Prof Emma Sciberras
The Sax Institute
Catherine Antonietta Emerson
Thesis entitled: Exploring the development of a psychological intervention to manage fatigue in Inflammatory Bowel Disease (IBD)
Doctor of Philosophy (Psychology), School of Psychology
Melissa Maas
Thesis entitled: Treatment decision-making in early stage non-small cell lung cancer patients and their support people
Doctor of Psychology (Health), School of Psychology
Katrine Turoy-Smith
Thesis entitled: Exploring the interviewing of children for family law matters
Doctor of Psychology (Forensic), School of Psychology
Co-supervisor
Kimina Lyall
Thesis entitled: Moodfulness: investigations into mindfulness, depression, inflammation, and subjective wellbeing homeostasis.
Doctor of Psychology (Clinical), School of Psychology
Eliza Hartley
Thesis entitled: The Postpartum Associations between Depression, Anxiety, Body Image and Weight


Get your project management certification. Easily maintain it.
Focus on the goals most specific to your career.
Never lose track of your certification goals. Make your life a little easier.
Whether it's achieving or maintaining a certification, CertiPro is here to help. CertiPro easily documents your progress in a mobile way.
Shows the requirements for every certification.
Helps document your experience and education in a progressive way.
Assesses how your experience and education match against your desired certification.
Measures your progress in a clear, visual dashboard.
Shows you a roadmap to your goals.
Tracks your progress against the requirements.
Shows the specific areas that require attention.
Reminds you to document your progress.
Stop worrying about how to get certified. With CertiPro, you can focus on more important goals. It just makes life easier.
Copyright © 2018 CertiPro. All rights reserved. Patent Pending.


There goes your latest money-making scheme.
According to The Hollywood Reporter, China has banned online vendors from selling "insurance policies" linked to Taylor Swift's romance with Tom Hiddleston. Fans had been going through the Craigslist-esque Taobao online marketplace to purchase the policies, which promised pay out if Hiddleswift broke up. Taobao is now cracking down on these vendors, the Xinhua News Agency reports.
"As it is not strictly an insurance product, the sellers are not qualified as insurance sellers," the Alibaba Group, which owns Taobao, told THR. "So we have taken down such 'products' from the Taobao platform."
A Hiddleswift breakup would have reportedly allowed policy-holders to double their money. The "Bad Blood" singer and her British beau aren't the only celebrity couple under cynical scrutiny, however. Similar policies allowed users to wager on the longevity of Katy Perry and Orlando Bloom's romance; those too have been taken down.
Sigh. Guess everyone will just have to get jobs?


text:
Page 22 of 23 First ... 1220212223 Last
After playing, and beating, Nemesis twice on total co-op mode, I can say it's one of the most stressful games I've played. Just need to make a couple reference cards for noise rolls and intruder bag results to improve game flow.
^ Tabletop Bloodbourne.
Haven't played but thought this looked cool.
More: https://www.reddit.com/r/Games/comme..._game_trailer/
Actually, the kickstarter launches next Tuesday, and since it's CMON who are publishing the game (Blood Rage, Rising Sun, Zombicide), you know the production values are going to be off the charts.
Goddamnit....
So, this Tuesday, I'm going next level board game nerd - a local game publisher, Leder Games, the folks behind the wildly popular game Root, just completed a successful campaign for an expansion to the game. They need some playtesters, so I applied to be one, and holy shit, they actually accepted my application. Suckers!
Anywho, I've been wanting to play this game for awhile. Everybody i know who's played it loves it to pieces, and to get to play the expansion months before it hits retail is gonna be cool as hell.
That is SO cool.
Did you tell D_Davis?
No, I haven't told Dan - I should tho.
Just got back from playtesting for Root. They were looking for folks who had never played it to test out a tutorial they have created designed to quickly acclimate people to the rules. Great idea, I wish more games came with a tutorial - I've only played one other game that did, and it, like this one, really got me up to speed on the rules fast.
At any rate, any of you looking for an adorable but cutthroat game, where your gameplay options are nothing like the other people you're playing against, then Root is definitely something you need to check out.
Played Lords of Hellas twice at Caste-de-Bac0n today. Had a good strategy going the first game until bac0nette usurped one of my regions to win the game.
Second playthough i pulled out a victory. It looked like it was going to be a cake walk with my massive army defending the completed Athena monument, but then the other three players started building monuments just so they could trigger monster movements / attacks.
In the end, my massive army was decimated by monsters and Scar-ette's final push. I was sitting on rather powerful combat cards, and Achilles sacrificed the last of his troops to maintain control of the completed monument after three turns.
Trust me, it'll make more sense after you've played the game.
Yeah, Lords of Hellas is a fun game for those who like a fast-paced area control sort of game with lots of ways to win. It's the first boardgame kickstarter I backed, and the stretch goals showed up last friday. There are lots of them. Lots and lots and lots of them - to the point that a significant part of my game shelf is LoH focused. Needless to say, we will be revisiting this game quite a bit.
I've said it before, and I'll say it again: Buy Bunny Kingdom.
I think Scar-ette is going to impose a three martini minimum before I'm allowed to play, since that's the only time she's won. Granted, it was her birthday.
I played a fun new game last night for the first time: Outer Rim. It takes place in the Star Wars OT universe, in the grungy outskirts of the galaxy. You take on the role of a rogue of sorts, pulling off jobs, smuggling contraband, collecting bounties, all to get money to upgrade your ship (or purchase a new one) and build your fame. First person to 10 fame points wins.
I was Bossk, so I did the bounty hunter thing and went after Dr. Evazan (the guy with death warrants on 12 systems, one of which apparently was Mon Calamari, who paid nicely for him, enough for me to purchase Slave 1). I was in hot pursuit of Han Solo when another guy snuck out the win, the rat bastid.
All in all, a fun, fast game. Took a little over an hour and a half to play after setup and learning the rules. Highly recommend!
What are other people playing these days?
Bac0n dusted off Blood Rage yesterday, and we had a Viking themed game day, complete with robust beers, tasty food, and, well, Steve wore a kilt, so whatever.
I started getting evil looks from everyone since my score started taking off. Got to the point that I think I might be banned from playing it again.... ;-)
Hahaha we just need to get it to the table more often so we don't forget those little things called quests. I was too preoccupied with getting cool monsters on the board and fighting and totally forgot all about it.
This is kinda neat - the fine folks at PubMeeple have created an engine that takes a list of games (or books or songs or whatever) that you input, and asks you a series of which would you rather play questions to determine how they rank in terms of your favorites. Cooler still, if you have your collection listed on BoardGameGeek.com (which I do), then the engine will suck that list right in for you. Anywho, here's what it has for my top ten favorite games at the moment, and I must say, it's pretty spot on.
10 Viticulture Essential Edition
Your parents have died and left you with a couple fields, some crush pads and a wine cellar - your job is to grow it into the best winery in Tuscany by planting vineyards, harvesting and crushing grapes, cellaring wines, and ultimately filling wine orders. A perfectly chill worker placement game to be enjoyed with a nice sangiovese. Scar - we need to get Scarette playing this - professional development.
9 Lords of Hellas
Think Clash of the Titans with robots and lasers. The Greek gods are giant cyborg aliens, and you're a hero of Greek myth trying to lead your laser-wielding army to victory. It's a fun fast-paced game with a good flow, many ways to win, and a fun way in which everything pretty much goes batshit crazy during the last few turns.
8 Tokaido
This is the game that got me into boardgaming. I saw Wil Wheaton playing it on his webseries TableTop and I was sold. You play a traveler working your way along the eponymous route in Japan that goes from Kyoto to Tokyo. It's not a race; rather, you're trying to have as amazing a vacation along the way as possible, shopping, eating, meeting interesting people, collecting art. The artwork is beautiful and the vibe is very laid back. There's a spiritual sequel, Namiji, coming out this fall - can't wait!
7 Joking Hazard
Looking for a Cards Against Humanity game that isn't Cards Against Humanity? Joking Hazard is your ticket. You're basically competing to create the funniest 3-panel comic - with the salty humor you would expect from the demented minds behind Cyanide and Happiness. Definitely not for kids.
6 PARKS
A celebration of our national parks, your job is to go on hikes each season, collecting tokens along the way, and at trail's end, you use those tokens to visit some of the more iconic national parks in the country, which gives you points. The winner is the one who has the most points at the end of four seasons. In terms of artwork, PARKS is probably the most beautiful game in my collection. Each one of those park cards I would hang on my wall if it were a print (and most of them are indeed available as prints, goodbye bank account).
5 Rising Sun
It's feudal Japan, the emperor's dead, and you play the daimyo of a mighty clan trying to position yourself as the natural successor, enlisting your armies, oni, and even the gods themselves for help. This is a game I don't get to the table nearly as much as I would like. It says 3-5 players, but really you need at least four, as diplomacy and forging alliances is a huge part of the game, and trust me, you don't wanna be the odd man out. Regardless, the production values of the miniatures are off the charts, and it looks glorious towards the end when all of those minis are on the board. Noteworthy: last time we played, Scar managed to win via mass seppiku.
4 Western Legends
It's the Wild West and you're out to be the biggest legend that ever was. The fun in this game is that you get to decide how you go about carving out that legend: you can go the lawman route like Wyatt Earp or Allan Pinkerton, you can rob banks (and other players) and hold up trains like Jesse James or Butch Cassidy, you can earn your fame at the poker tables like Doc Holliday, or just go batshit crazy all over the place like Calamity Jane or Buffalo Bill. Or maybe any combination thereof, it's really up to you. Things get really fun when there are a lot of people playing at the same time, running into each other in interesting ways and interweaving their stories. Noteworthy: last time we played, Scar managed to win by blowing all his money on strippers.
3 Mansions of Madness: Second Edition
If you want to play a game that feels like you're trapped inside of an HP Lovecraft novel, MoM is your ticket to... um, well paradise might not be the appropriate word here, but it sure is fun. What's cool about this game is that it comes with a companion app which acts as a DM, taking care of the heavy lifting and rules management, so you can get someone new to the game going real quick and focus on unraveling the mysteries and horrors that lurk in every room. And, oh, the atmosphere, the slow burn of the tension as it builds from a subtle, nebulous dread to full on panic and race for survival, is so exhilarating.
2 Scythe
If you were to judge my favorite boardgame by how many times it hits the table, Scythe would be on top, hands down. Taking place in a fictional 1920s eastern Europe, you command a faction trying to rebuild itself in the ashes of a great war that saw giant steam powered mechs thundering across the countryside, and the city-state, known only as "The Factory", that produced all these mechs lies abandoned and waiting to be exploited. The fun thing about this game is that there are so many levers to pull, so many paths to victory, and it plays so differently depending on whether you are playing alone, with two players, or with seven. And it doesn't hurt that the art direction is gorgeous and production values are top notch, and that Jamey Stegmaier, the gamne's designer, is super engaged with the community.
1 Cthulhu: Death May Die
I've only had this game for a few months, and already it has made it to the table more times than games that I have had for years. Why? Because it's just plain fun. While Lovecraft purists will complain that it doesn't capture the spirit of the novels at all (and they're right), my counter-argument would be that sometimes you just gotta shoot Cthulhu in the face with Ernest Hemingway. Or rig cows with dynamite so they blow up their alien kidnappers. Or MacGuyver up a bomb as Albert Einstein and blow up a room full of cultists. Can I get a hell yeah?
What are your favorites at the moment?
Last edited by bac0n; 03-06-2020 at 10:44 PM.
Well, I finally broke my self imposed 'Not Buying Games Bac0n' owns rule.
Mansions of Madness 2nd Edition was $69 on Amazon, so I ordered that, Streets of Arkham and Beyond the Threshold expansions. And I'm seriously anxious to play Death May Die.
The game based on They Live! is live on KS and looks neat.
Looks kick-ass, but I have no less than five KS games backed that I haven't yet received, and I'll be backing Ankh (the spiritual sequel to Blood Rage and Rising Sun) on the 14th. After that, I really need to take a break from kickstarter.
I do like how the game incorporates special sunglasses as a gameplay element.
What is Ankh?
Quoting CMON
Play as a god of ancient Egypt, competing to survive as society begins to forget the old ways, so that only you and your followers remain.
Build caravans, summon monsters, and convert followers in your quest to reign supreme in Ankh: Gods of Egypt. Deities, monsters, and the people of ancient Egypt have been lovingly reimagined and interpreted in beautiful illustrations and detailed miniatures, and players will truly feel like gods as they shake the very foundations of Egypt. All gameplay in Ankh, including combat, is streamlined and non-random. Compete and win solely on your godly wits alone.
https://www.boardgamegeek.com/boardg...nkh-gods-egypt
That sounds...very cool.
Backed the new Sandy Petersen game, Dinosaur 1944.
Looks like a lot of fun.
Dinosaurs and army men: sounds like a can't miss to me...


Using an African indigenous mightily nutrient dense green that it's time to return to, and for many of us – sadly to be introduced to. I say sadly – because this has been a staple food for many South Africans and yet the divide between us has had it not feature in traditional retail. For those of you with fond and rich memories of mothers and grandmothers cooking this for you, thank you so much for sharing them with us, I used them to try it for the first time. For those of you new to it, you may not want to revere baby spinach as much as you have done before. This green is more relevant.
Known by many different names reflecting the variety of languages and cultures we are here – it is known as amaranth, moroggo, imfino, imbuya or tepe and it's absurdly delicious and a great African green to include in your diet.
It is brought to us by Siphiwe from African Marmalade who is making it her life's work to grow relevant African food and bring it closer to us.
So this is what I did with it and this is only the beginning. Next week we'll be bringing you a great recipe for cassava leaves which Siphiwe blends up into a paste for us that yells – LARGE AMOUNTS OF CHLOROPHYLL HERE RIGHT NOW.
Ground nuts are another feature of African indigenous eating and cooking and seem to always feature with greens so it was a joy to use them. Ground nuts are not in the same family as 'nuts' – they are more a legume. My daughter has an immediate reaction to any form of nuts as does her Father and yet they had no reaction to these at all.
Dash Salt & Pepper I added a dash of kimchi salt & it was delicious!
Heat the olive or coconut oil in a pot on the stove – keep heat low.
Throw in the tomatoes and cook for another 5 minutes, stirring all the time so that it doesn't burn. Once the tomatoes are in, you can turn up the heat.
Throw in the imbuya leaves, stir through once and then throw the ground nuts on top of that – don't stir them through - then put the lid on your pot so that the leaves wild down into your onion mixture for 5 minutes.
Start stirring it all through. There is little water in imbuya so once the greens are wilted down, you then add a ¼ cup of coconut cream and stir through.
Notes: chilli would work well in this too, I can't use it because my daughter hates it.


text:
Pols push statewide break for seniors using muni-meters
May 11, 2012 Brooklyn Eagle Staff
Bay Ridge — Al Asfazadour, president of Bay Ridge's AARP Chapter #5055, said that seniors often have trouble operating the new muni-meters that line the neighborhood's busiest shopping thoroughfares.
"Have you ever tried to work one of these?" he asked, pointing to a muni-meter on Fifth Avenue and 75th Street last week. "They're very complicated."
A New York City law gives motorists a five-minute grace period in which to get a parking receipt from a muni-meter, but two local lawmakers said not enough people know about it. Moreover, it should be a state law, they said.
State Sen. Marty Golden and Assemblywoman Nicole Malliotakis held a press conference next to a muni-meter on Fifth Avenue near 75th Street to announce that they are sponsoring bills in their respective legislative houses to expand the city law statewide.
Under their proposal, a driver would get help fighting an unfair parking ticket. If the time stamped on the muni-meter receipt is within five minutes of the time the summons is issued, the motorist has a good weapon with which to fight to get the ticket dismissed, Malliotakis said.
The goal is to protect drivers from overeager traffic enforcement agents who pounce on them, Malliotakis said. Often, a motorist will park the car, walk to a muni-meter to purchase a parking receipt, and receive an unhappy surprise when they return to the vehicle, she said.
"In the time they get back to the car, they've received a summons," she said.
In some cases, there aren't that many muni-meters on an avenue, according to Malliotakis, who said a driver has to "walk to the next block."
That gives the enforcement agent more time to issue the summons, she said.
"There are many senior citizens in this community. Obviously, seniors take much longer to get out of their car and walk to a muni-meter," Malliotakis said.
Golden, who said the bill is "legislation that the City Council did wisely," said it should be a state law.
"Regulations must take into account that we don't always get a parking spot right next to a muni-meter machine. While there are many benefits to muni-meters, they have created a new opportunity for motorists to receive unwarranted parking tickets," he said.
Golden and Malliotakis also said that another purpose of their sidewalk press conference was to bring attention to the city law. The law was passed by the City Council last year and was vetoed by Mayor Michael Bloomberg. The Council overrode the veto and the bill became law. Many residents don't know about the law and don't realize that the five-minute grace period exists, the two lawmakers said.
"We want to bring attention to this new law," Malliotakis said.
"We have a very large senior population," he said, explaining that older drivers often need more time to figure out the workings of the muni-meter.
— Paula Katinas
https://brooklyneagle.com/articles/2012/05/11/pols-push-statewide-break-for-seniors-using-muni-meters/


January is the month the racing world flocks to the racetracks of Florida, making facilities such as Daytona International Speedway, Homestead-Miami Speedway and Sebring International Raceway their homes away from home.
This week the Verizon IndyCar Series opened its preseason testing period for the 2018 season, with Andretti Autosport, Chip Ganassi Racing and Dale Conye Racing taking full advantage by hitting the track in the first available days.
Playing host to the three Honda affiliates, Sebring will be a hotbed for IndyCar testing over the next two months as teams prepare for the rugged street circuit at the Firestone Grand Prix of St. Petersburg on March 11. Getting their first chance to run the new 2018 universal aero kit, Andretti Autosport brought each of its full-time drivers to the midweek session.
As always with the start of a new season, excitement levels are high between teams, drivers and their crew members. In these times, social media becomes a great place to get an inside look (or at least a taste) of what is going on during the offseason.
To mark the occasion, Open-Wheels has compiled the most interesting posts from the past two days in a Sebring testing special. It includes new looks at the cars participating in this week's test, video of cars on track and more! There has been some great and interesting content posted from the test and we wanted to compile it in one place for the fans.
Check out social media round-up from the January 9th and 10th test at Sebring International Raceway.
Today's the day!! First official test day with @FollowAndretti in the new @IndyCar here at @sebringraceway.


Nabumetone belongs to the group of medications known as nonsteroidal anti-inflammatory drugs (NSAIDs). It is used to reduce pain, swelling, and stiffness caused by rheumatoid arthritis and osteoarthritis. This medication usually starts to work to relive pain within an hour, but it may take up to 1 week before you feel its full effect.
The recommended dose of nabumetone ranges from 1,000 mg daily to 2,000 mg daily taken in 1 or 2 divided doses, with or without food. If this medication upsets your stomach, take it after a meal or with food or milk. Remain standing for 15 to 30 minutes after taking this medication. It is best to take nabumetone at the same time each day. The tablets should be swallowed whole and not chewed.
Each white, film-coated, capsule-shaped tablet with "G" on one side and "NB 500" on the other side contains nabumetone 500 mg. Nonmedicinal ingredients: microcrystalline cellulose, sodium lauryl sulphate, saccharin sodium, hydroxypropyl methylcellulose, sodium starch glycollate, magnesium stearate, titanium dioxide, polyethylene glycol, and talc.
Allergic reactions: If you have had a reaction to acetylsalicylic acid (ASA) or other NSAIDs (e.g., ibuprofen, ketoprofen, diclofenac) that included a runny nose, itchy skin rash, nasal polyps, or shortness of breath and wheezing, you should not take this medication. If you experience symptoms of a severe allergic reaction (e.g., hives; difficulty breathing; wheezing; swelling of the face, tongue, or throat), get immediate medical attention.
Fluid and electrolyte balance: This medication can cause fluid retention. If you have heart failure, high blood pressure, or other medical conditions that increase your risk of fluid retention (e.g., kidney problems), discuss with your doctor how this medication may affect your medical condition, how your medical condition may affect the dosing and effectiveness of this medication, and whether any special monitoring is needed.
Nabumetone may also cause high blood potassium levels. If you are a senior; have diabetes or kidney failure; or are taking beta-blockers (e.g., metoprolol, atenolol), angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril, enalapril), or some diuretics (e.g., triamterene, amiloride), you are more at risk of high blood potassium.
Infection: As with other anti-inflammatory medications, nabumetone may mask the usual signs of infection.
Kidney function: This medication can affect kidney function. You have a higher risk of developing kidney problems if you are a senior; take diuretics (water pills; e.g., hydrochlorothiazide, furosemide); or already have kidney disease, liver disease, or heart failure.
Your doctor may monitor your kidney function with blood tests if you take this medication. If you have kidney disease or reduced kidney function, discuss with your doctor how this medication may affect your medical condition, how your medical condition may affect the dosing and effectiveness of this medication, and whether any special monitoring is needed.
Liver problems: This medication may affect your liver function or cause liver problems. If you experience symptoms of liver problems (e.g., nausea, vomiting, feeling tired, yellowing of the skin or eyes) contact your doctor immediately. If you have liver problems, discuss with your doctor how this medication may affect your medical condition, how your medical condition may affect the dosing and effectiveness of this medication, and whether any special monitoring is needed.
Sun sensitivity: This medication may make your skin more sensitive to sunlight (including sunlamps) and may cause sunburn; skin blisters; and skin redness, itching, or discolouration. If you have a reaction from the sun while taking this medication, contact your doctor.
Ulcers and bleeding in the stomach and intestines: This medication can cause stomach ulcers, perforation (holes), and bleeding from the stomach. These complications can occur at any time without warning, and are sometimes severe enough to require immediate medical attention. The risk of ulcers and bleeding increases if you are taking higher doses of nabumetone for longer periods of time.
Stop taking the medication and get immediate medical attention if you experience symptoms or signs of stomach ulcers or bleeding in the stomach (black, tarry stools; blood in stools; stomach pain; vomiting blood or coffee grind material). These reactions can occur at any time during treatment without warning.
Vision: Blurred vision has occasionally been reported with the use of this medication. If this symptom develops, stop taking nabumetone and contact your doctor.
Pregnancy: This medication should not be used during the first 6 months of pregnancy unless the benefits outweigh the risks. If you become pregnant while taking this medication, stop taking it immediately and call your doctor. This medication should not be used during the last 3 months of pregnancy.
Breast-feeding: Taking this medication while breast-feeding is not recommended since the safety of doing so has not been established.
Seniors: Seniors appear to have a higher risk of developing side effects from this medication.


text:
Robert Caro
Biographer Robert Caro introduces his latest volume "The Passage of Power," in his series about Lyndon Johnson.
Books History
February 2014 November 2013 January 2013 January 2013 January 2013 January 2013 May 2012 February 2012 April 2009 April 2009
Jony Ive and Marc Newson; Robert Caro
Books, History, Art and design
Designers Jony Ive and Marc Newson on Bono's nonprofit Red; Robert Caro on his latest book, "The Passage of Power." 53:39
Jeff Shesol
Politics, Books, History
Historian Jeff Shesol presents his new book, "Mutual Contempt: Lyndon Johnson, Robert Kennedy, and the Feud That Defined a Decade." 19:25
Joseph A. Califano, Jr. Pt. 2
Joseph A. Califano, Jr., former Secretary of Health, Education and Welfare, talks about President Lyndon B. Johnson, Vietnam, the Kennedy... 07:32
'Two Men of Florence'
Entertainment, Politics
Richard and Doris Kearns Goodwin discuss their family and his play, "Two Men of Florence." 19:25
Jeff Greenfield
Author Jeff Greenfield looks at alternative histories of American politics in his book, "Then Everything Changed." 20:59


First, thank you all for the great educational material provided in the forum. I was incredibly ignorant of how to use a NAS when I got my QNAP TS-453A, and without this forum I'd be using it as little more than a Time Machine for the Macs in my house.
I just added my SSL certificate and I went to access the device via the device.myqnapcloud.com URL and it does not come up. From inside the myqnapcloud site, I can access the device's QTS but it comes up with my local address. Is there a place I am supposed to setup the dynamic DNS that I am missing?
I searched the help but I am pretty sure I've overlooked something obvious.
Yes. That doesn't relate to the problem -- thanks for trying to help.
Maybe I didn't explain it well? Apps such as qfile work just fine on my mobile devices and away from home. What doesn't work is QTS from the device.myqnapcloud.com -- I thought maybe there was some other place I needed to setup the ddns or something else I missed.


text:
Chapter 215: Circling Around Behind It, Stealing the Spirit Essence
The scene within the cavern was a complete chaotic mess. After the first spirit creature was swallowed, it was quickly followed by a second and then a third.
The devouring appetite of the Lotus was incredibly frightening. Once a spirit creature was enclosed by it, it would be unable to break free at all and struggle until it died.
Some stronger spirit creatures with faster reactions immediately understood what was happening and fled when they saw the other spirit creatures being devoured by the petals of the Lotus.
However, the hundreds of vines around the chasm were like hundreds of tentacles as they formed a dense net surrounding everything.
Add to that the enormous mouth that was the Lotus, the spirit creatures were unable to escape from the encasement of the sea of vines no matter where they fled.
Jiang Chen immediately spurred on the Rat King when he took in the situation. "Ole Gold, hurry, and follow me down. We'll circle around behind it."
"Behind it?'
"Don't ask and follow my instructions. We need to be quick, so hurry." Jiang Chen rushed the Rat King onwards and started drilling towards the depths of the ground.
The Rat King also used all of its strength as it moved like it was swimming through water. The rock walls didn't affect its speed at all whilst drilling.
One had to admit, the Goldbiter Rats had a great talent in drilling indeed.
"Mm, we're about two to three thousand meters in. This is the place." Jiang Chen calculated accurately using the Psychic's Head.
Indeed, when the walls were broken through, a man and a rat found themselves at the bottom of the chasm.
In front of Jiang Chen's Psychic's Head, any place was like bright daylight for him and his vision wasn't impaired at all. Add to that searching with the God's Eye, he quickly locked onto the right location.
"Go, over there, that's the place."
The temperature was actually as warm as spring beneath the chasm. Neither the bone piercing cold nor the blazing hot fire was present.
Jiang Chen knew that this was the balance formed by the Flaming Heart of Ice. It was only under these conditions that the evolution of the Heart would be the fastest.
"Hurry, hurry, we must be fast!" Jiang Chen threaded through the bottom of the chasm.
He knew that he was in a race against time with the Lotus and hoped that the spirit creatures would be able to contain it for a bit longer.
Jiang Chen would be safe as long as the Lotus hadn't completely retreated.
He'd have to face hundreds of Lotuses by himself if the Lotus finished its meal and withdrew!
Every single one of those Lotuses was at least at the peak of the spirit realm.
Once that happens, Jiang Chen would be dead without a doubt.
However, if Jiang Chen was able to get to the Heart and absorb it before the Lotus does, then all the Lotuses would immediately wither without the support of its spirit essence. They wouldn't be able to threaten him then.
Time was of the essence, and it was now a race against time.
Jiang Chen's footsteps suddenly halted as fog billowed upwards in front of him. It gave one a mysterious feeling like finding an altar in the middle of water.
"That must be the place!"
Jiang Chen's heart suddenly pounded because he knew that this was an opportunity, but one that came with a lot of risks.
He was about to rush over when his footsteps abruptly halted because he discovered that there were eight vines around the altar in the water. There were eight Lotuses around the altar, protecting it tightly.
"Damnit, this Heart is extremely cautious alright." Jiang Chen was depressed as hell. He could see the item in front of him, but he had no way to get to it.
Each of the eight Lotuses were at the peak of the spirit realm. To approach with Jiang Chen's current level of training meant seeking death.
However, he wasn't willing to leave empty handed.
"Ole Gold, we may have to sacrifice some of your descendants!" Jiang Chen turned and said to the Rat King.
The Rat King smiled ruefully. "Must we really do this?"
"If I don't become stronger, how can I help your tribe become stronger?" Jiang Chen was quite rational.
The Rat King laughed wryly, "I almost don't know whether this choice is worth it or not."
"Ole Gold, this doesn't sound like you."
"Say no more. I'll summon a group of children to attract the eight Lotuses. As for whether you can obtain what you want, that will be up to you!"
"Alright. As long as your descendants can distract them for three to five minutes, I promise that I'll have the item in hand!"
The Rat King didn't hesitate as it summoned a couple thousand Rats to rush towards the altar within the water.
The Goldbiter Rats were as fierce and fearless as always, regardless of what environment they were in. They rushed towards the altar and started ferociously tearing away at the vines of the eight Lotuses.
Jiang Chen laid in wait until all eight Lotuses were contained by the Rats before taking a leap upwards and landing on the altar within the water.
Jiang Chen looked downwards and saw a spirit item shaped like an infant on the altar. It was half blue and half red, sparkling like a crystalline entity and exuding an astonishing presence.
The dense vines around the spirit item were obviously born from it and were extending from it.
"This is the Flaming Heart of Ice!"
Jiang Chen was about to reach out and grab it when his hand was almost burnt to a crisp by a wave of heat before he'd even touched the Heart.
He hastily snatched his hand back.
"That's right, the Heart is half blazing flame and half frosty ice. I'll be unable to take it without using special equipment. I'd only be able to destroy it."
"However, if I can use the mysteries of the Divine Aeons Fist and hold the moon in one hand and the sun in the other, wouldn't that happen to match the mysteries of the Heart?"
Jiang Chen's hands twisted into certain hand seals as he deployed the mysteries of the Divine Aeons Fist. He held the sun in one hand and the moon in another, and placed both hands on the Heart.
"What are you?!"
"A lowly human dares to pollute me?!"
"Damn it, what are you doing?! Don't touch me!"
The Heart possessed inordinate intelligence. How else would it give birth to so many Lotuses to swallow the spirit creatures, absorb their spirit power, and help itself evolve?
However, the Heart itself had no battle capabilities. It couldn't resist at all with both of Jiang Chen's hands on it.
"Human, are you absorbing my spirit power? No, you're actually refining me! How… how are you doing it? You can actually refine me?"
The Heart was panicking by now. It hastened to summon the Lotuses back to attack Jiang Chen.
Indeed, it wasn't long afterward before the Lotuses on the surface of the chasm were continuously summoned back down by the Heart.
The Rat King on the side was resigned. It obviously couldn't watch Jiang Chen be swallowed by the Lotus, so it could only continuously summon out its children and use the tactic of superior numbers to continuously harass and restrain the Lotuses.
It was a good thing that Jiang Chen had a high comprehension of the Divine Aeons Fist. Furthermore, he had studied the Lotus in depth. This continuously boosted his rate of absorption.
As his rate increased, the Heart's defensive capabilities decreased. The amount of Lotuses it could control also continuously decreased. As its spirit essence was continuously siphoned away, the attacks of the Lotuses it had summoned downwards also grew weaker and weaker.
Finally, when Jiang Chen retracted his hands after fifteen minutes, the Heart had disappeared completely from the altar within the water as it'd been completely absorbed by Jiang Chen.
The vines from all the Lotuses also swiftly withered at a noticeable pace after the Heart had disappeared.
Jiang Chen quickly dashed out of the altar and came to the side of the Rat King. "Hurry, let's go."
The Rat King summoned the rest of his children to return back into the Stonenest as they left hurriedly through the tunnels they had come from, leaving behind a scene of devastation.
All of the spirit creatures who had survived the disaster came down not long thereafter.
All of the Lotuses had withered and died above the chasm, this greatly shocked the spirit creatures hanging on by the tips of their claws.
Although there were only less than a third of the spirit creatures left at this point, those who could survive until now weren't your average strong spirit creature.
They weren't satisfied with merely living through what'd seemed like sure death, and wanted to investigate the bottom of this chasm.
They were all greatly astonished when they happened upon the scene of great devastation.
"It was this altar controlling the Lotuses?"
"No, there's no spirit power on this altar at all, how could it have controlled the Lotuses?"
"Eh? There's the lingering presence of humans here?"
"Can it be that a human secretly snuck in and stole the spirit essence of the Lotus?" A spirit creature who had great knowledge suddenly remembered the matter of the spirit essence.
"A human?"
"Everyone, come look, there's a passage here!"
"There really is a passage! This must be how the human got in."
"Yes, judging from this size, it looks big enough for a human."
"That's odd, this passage looks new. Does the human know how to drill through the earth? This is a bit strange."
"Whatever, after the human!"
A few smaller sized spirit creatures rushed into the passage and tried to follow it.
A few bigger spirit creatures couldn't squeeze themselves in no matter how they tried. They could only go back the way they had came and take a look at the situation when they got to the surface.
Except, Jiang Chen was as if a fish in water at this moment. He quickly arrived back in the outside world thanks to the Rat King guiding him.
After the Rat King returned to the Stonenest, Jiang Chen rushed out of the cave with the fastest speed possible and left the mountain valley.
He had no worries after he left the valley. The maze realm was so vast, he only needed to retract his presence to make it impossible for the spirit creatures to follow him.
After he ran madly for a thousand li, Jiang Chen found a quiet area and had the Rat King dig a cave. He hid in it and started closed door cultivation.
After absorbing the Heart, Jiang Chen's current spirit ocean almost wanted to explode. He needed to cultivate behind closed doors for a moment to fully subvert the heart for his own use.
It was also Jiang Chen's good luck that he'd trained in the Divine Aeons Fist and had a high grasp of its mysteries. There was no way he could taken the Heart otherwise.
Any practitioner who hadn't grasped the concept of the sun and moon and the dual existence of the yin and yang would've been directly burnt to a crisp by the power of fire or frozen into an ice cube by the power of ice if they'd brashly tried to take the Heart.
It was only through dual employment of the yin and yang and alternatively absorbing each side could the Heart be slowly absorbed.
Jiang Chen also knew that he'd made out like a bandit this time. The Autumn Hunt had finally not been in vain.


The Ministry of Health (MoH) is the lead of the Health and Nutrition cluster. The World Health Organisation is the co-lead and supports the Ministry of Health to strengthen existing health systems and to ensure that government priorities are being followed. The Health Cluster serves as a mechanism for national and international organisations to work together in partnership to harmonise efforts and to use available resources efficiently.
The overall goal of the Health and Nutrition cluster is to reduce mortality and morbidity, and restore the delivery of preventive and curative health care as quickly as possible in an equitable, sustainable manner.